uniQure N.V. Amortization of Intangible Assets
uniQure N.V. (QURE) reported Amortization of Intangible Assets of $100.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2018-11-06
- uniQure N.V. amortization of intangible assets for the quarter ending 2018-09-30 was $100.00K, a 0.00% change year-over-year.
- uniQure N.V. amortization of intangible assets for the quarter ending 2018-06-30 was $100.00K, a 85.71% decline year-over-year.
- uniQure N.V. amortization of intangible assets for the quarter ending 2018-03-31 was $100.00K, a 0.00% change year-over-year.
- uniQure N.V. amortization of intangible assets for the quarter ending 2017-09-30 was $100.00K, a 0.00% change year-over-year.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month |
|---|---|---|---|
| 2018-09-30 | $100.00K 10-Q · filed 2018-11-06 | $200.00K derived: sum of 2 quarters · filed 2018-11-06 | $300.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $100.00K 10-Q · filed 2018-08-08 | $200.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $100.00K 10-Q · filed 2018-04-30 | ||
| 2017-09-30 | $100.00K 10-Q · filed 2018-11-06 | $800.00K derived: sum of 2 quarters · filed 2018-11-06 | $900.00K 10-Q · filed 2018-11-06 |
| 2017-06-30 | $700.00K 10-Q · filed 2018-08-08 | $800.00K 10-Q · filed 2018-08-08 | |
| 2017-03-31 | $100.00K 10-Q · filed 2018-04-30 | ||
| 2016-09-30 | $100.00K 10-Q · filed 2017-11-01 | $300.00K derived: sum of 2 quarters · filed 2017-11-01 | $400.00K 10-Q · filed 2017-11-01 |
| 2016-06-30 | $200.00K 10-Q · filed 2017-08-08 | $300.00K 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $100.00K 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |